FINWIRES · TerminalLIVE
FINWIRES

Medical Facilities Q1 Net Earnings, Revenue Higher

作者

-- Medical Facilities (DR.TO) first quarter net earnings and revenue both climbed, the company said on Thursday.

Net earnings jumped 86% to US$13.1 million, or US$0.21 per diluted share, from US$7.05 million, or US$0.12 per share, in the prior year period.

Revenue grew 10.8% to US$67.1 million.

"We had a strong first quarter, driven by a favourable payor mix as well as higher volumes of orthopedic and spine procedures," said chief executive Jason Redman.

"During the quarter, we continued our several-year track record of returning capital to shareholders through our NCIB. However, the big highlight for the quarter came in January with the sale of our majority interest in OSH for gross cash proceeds of approximately $46 million. We ended the period with a very solid balance sheet and a robust cash position, providing us with significant financial strength and flexibility to continue investing in our hospitals and returning capital to our shareholders."

Medical Facilities closed down $0.14, to $16.96, on Wednesday on the Toronto Stock Exchange.

相關文章

Australia

Vericel股價上漲,此前該公司公佈第一季淨虧損收窄,營收成長;並上調了2026年營收預期。

Vericel (VCEL) 股價週四上漲 1.3%,此前該公司公佈第一季淨虧損收窄、營收成長,並上調了全年營收預期。 該公司週四公佈的第一季每股攤薄虧損為 0.12 美元,較去年同期的 0.23 美元虧損收窄。 FactSet 調查的分析師此前預期虧損為 0.15 美元。 截至 3 月 31 日的第一季營收為 6,840 萬美元,高於去年同期的 5,260 萬美元。 FactSet 調查的分析師先前預期營收為 6,370 萬美元。 該公司表示,目前預計 2026 年全年營收將在 3.26 億美元至 3.36 億美元之間,高於先前預期的 3.16 億美元至 3.26 億美元。 FactSet 調查的分析師先前預期營收為 3.234 億美元。Price: $37.26, Change: $+0.48, Percent Change: +1.31%

$VCEL
Australia

流動性服務公司第二財季調整後獲利及營收成長;股價下跌

儘管Liquidity Services (LQDT)公佈的第二財季調整後盈利和營收均同比增長,並超出分析師預期,但該公司股價在周四早盤交易中仍下跌近2%。 該公司公佈的第二財季調整後每股收益為0.35美元,高於去年同期的0.31美元。 FactSet調查的兩名分析師先前預期為0.30美元。 截至3月31日的季度營收為1.207億美元,高於去年同期的1.164億美元。 FactSet調查的一名分析師先前預期為5,290萬美元。 該公司預計第三財季調整後每股收益為0.30美元至0.39美元。 FactSet調查的兩名分析師先前預期為0.37美元。Price: $35.83, Change: $-1.39, Percent Change: -3.73%

$LQDT
Australia

奧本海默將Trimble的目標股價從86美元下調至80美元,維持「跑贏大盤」評級。

根據FactSet調查的分析師數據,Trimble (TRMB) 的平均評級為“買入”,平均目標價為87.33美元。 (報道北美、亞洲和歐洲主要銀行及研究機構的股票、商品和經濟研究。研究機構可透過以下連結聯絡我們:https://www..com/contact-us)Price: $63.47, Change: $+0.05, Percent Change: +0.08%

$TRMB